meta分析:音乐,缓解癌症患者疼痛和焦虑的有效手段

2012-04-10 卢秀玲 不详

       根据一项Cochrane数据库系统综述和Meta分析的结果,演奏乐器、唱歌或单纯收听音乐录音均可使肿瘤患者的焦虑评分显著降低。并且费城德雷克塞尔大学创造性艺术系的研究者发现,由医务人员或经过培训的音乐治疗师提供的各种音乐干预还可显著改善疼痛、情绪和生活质量评分等次要终点。        

       根据一项Cochrane数据库系统综述和Meta分析的结果,演奏乐器、唱歌或单纯收听音乐录音均可使肿瘤患者的焦虑评分显著降低。并且费城德雷克塞尔大学创造性艺术系的研究者发现,由医务人员或经过培训的音乐治疗师提供的各种音乐干预还可显著改善疼痛、情绪和生活质量评分等次要终点。

         加利福尼亚大学的Wendy Anderson博士在美国安宁缓和医学会年会上指出,之前关于对肿瘤患者进行音乐干预的研究规模都非常小,对相似程度较高、可以合并的小型研究进行Meta分析可以产生更强、更确切的结论。          这篇报告共纳入在7个国家进行的30项随机临床试验,包括1,891例不限年龄和各种肿瘤类型的参与者。总体上,13项试验由经过培训的音乐治疗师实施干预,另外17项研究中的干预包括收听患者选择的预先录制的各种流派音乐。一般每次治疗时间为30~45 min。不同研究中的治疗次数有很大差异。对照组的受试者接受常规治疗,一些研究中,对照组受试者通过耳机收听白噪音。          共有16项随机试验评估了焦虑水平。总体结果显示,音乐干预可达到有临床意义和统计学意义的焦虑评分降低,影响为中至大幅度。例如,在各种音乐干预后,状态特质焦虑量表的平均评分降低了11.2个单位,而对照组无变化。与此相似,音乐干预组较对照组疼痛评分的降低以及结构情绪和生活质量的改善也在中至大幅度范围内。“对于肿瘤患者,这些都是非常重要的预后指标,”Anderson博士说。          音乐治疗是一种明确的专业治疗方式。经过培训的音乐治疗师可对患者进行详细评估,并提供量身定制的音乐体验。尽管既往曾有研究者试图了解,由经过培训的音乐治疗师提供的更复杂和更积极的音乐干预,能否较医务人员提供的较简单的音乐收听干预产生更大幅度的心身预后改善作用,但由于研究数据库不够大,无法得出任何相关结论(Cochrane Database Syst. Rev. 2011 [doi:10.1002/14651858.CD006911])。          研究者总结认为,音乐干预可改善肿瘤患者的焦虑,并减轻疼痛,提高生活质量。          Cochrane综述由宾夕法尼亚州Formula基金资助。Anderson博士披露无相关利益冲突。 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1887315, encodeId=d371188e315a1, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 14 10:50:00 CST 2012, time=2012-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895619, encodeId=54f018956194a, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Oct 18 06:50:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289408, encodeId=0fc51289408d5, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426127, encodeId=42db142612e7b, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-05-14 guojianrong
  2. [GetPortalCommentsPageByObjectIdResponse(id=1887315, encodeId=d371188e315a1, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 14 10:50:00 CST 2012, time=2012-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895619, encodeId=54f018956194a, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Oct 18 06:50:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289408, encodeId=0fc51289408d5, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426127, encodeId=42db142612e7b, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-10-18 docwu2019
  3. [GetPortalCommentsPageByObjectIdResponse(id=1887315, encodeId=d371188e315a1, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 14 10:50:00 CST 2012, time=2012-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895619, encodeId=54f018956194a, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Oct 18 06:50:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289408, encodeId=0fc51289408d5, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426127, encodeId=42db142612e7b, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1887315, encodeId=d371188e315a1, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Mon May 14 10:50:00 CST 2012, time=2012-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895619, encodeId=54f018956194a, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Oct 18 06:50:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289408, encodeId=0fc51289408d5, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426127, encodeId=42db142612e7b, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Thu Apr 12 14:50:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 weiz